Erratum: Mina, R.; et al. Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives. J. Clin. Med. 2020, 9, 2142

Documenti analoghi

• Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives
  di: Mina, Roberto, et al.
  Pubblicazione: (2020)
• Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
  di: Oliva, Stefania, et al.
  Pubblicazione: (2020)
• Erratum: Iyer, A., et al. Integrative Analysis and Machine Learning Based Characterization of Single Circulating Tumor Cells. J. Clin. Med. 2020, 9, 1206
  di: Iyer, Arvind, et al.
  Pubblicazione: (2021)
• Erratum to “Network Analysis of Language Disorganization in Patients with Schizophrenia” by Park SC, et al. (Yonsei Med J 2020; 61(8): 726-730.)
  Pubblicazione: (2020)
• Comment on Morse et al. A Universal Pharmacokinetic Model for Dexmedetomidine in Children and Adults. J. Clin. Med. 2020, 9, 3480
  di: Eleveld, Douglas J., et al.
  Pubblicazione: (2021)